ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
천식 치료 시장 규모는 향후 몇 년 동안 안정적인 성장이 예상됩니다. 2029년에는 CAGR 4.5%로 282억 7,000만 달러로 성장할 것입니다. 예측 기간 동안 예상되는 성장은 맞춤형 천식 치료의 중요성 증가, 생물학적 제제 및 단클론항체의 채택 확대, 호흡기 약물에 대한 R&D 투자 증가, 원격의료 및 디지털 천식 관리 도구의 사용 확대, 만성 호흡기 치료에 초점을 맞춘 정부의 노력 강화 등과 관련이 있습니다. 예상되는 주요 동향으로는 중증 천식에 대한 생물학적 치료의 발전, 추적 기능을 갖춘 첨단 디지털 흡입기 개발, 맞춤형 의료 혁신, 약물전달 기술의 개선, AI를 활용한 천식 관리 플랫폼의 발전 등이 있습니다.
호흡기질환의 유병률 증가는 향후 몇 년 동안 천식 치료제 시장의 성장을 촉진할 것으로 예상됩니다. 호흡기질환에는 만성폐쇄성폐질환(COPD), 기관지염, 천식 등 폐와 호흡에 영향을 미치는 질환이 포함됩니다. 이 증가는 대기오염과 밀접한 관련이 있는데, 미립자 물질과 질소산화물이 기도를 자극해 염증을 유발하고 호흡곤란을 일으켜 천식과 같은 질환을 악화시키기 때문입니다. 호흡기질환 환자 수가 증가함에 따라 호흡기 염증 및 증상 관리를 위한 약물, 흡입기, 생활습관 개선 등 천식 치료제에 대한 수요가 증가하고 있습니다. 예를 들어, 2023년 12월 미국 국립의학도서관은 2050년까지 중저소득 국가의 COPD 환자 수가 고소득 국가의 2배 이상이 될 것으로 예상되며, 사하라 사막 이남 아프리카에서 59% 증가하여 2040년까지 COPD 유병률과 환자 수에서 세계를 선도할 것으로 예상된다고 보고했습니다. 이처럼 호흡기질환의 유병률 증가가 천식 치료제 시장의 성장을 촉진하고 있습니다.
천식 치료 시장의 주요 기업들은 천식 환자의 기도 염증에 대처하는 동시에 신속한 증상 완화를 제공하는 항염증제 구조 흡입기와 같은 혁신적인 제품 개발에 주력하고 있습니다. 항염증 구조 흡입제는 천식 발작 시 신속한 증상 완화를 제공하고 근본적인 기도 염증을 억제합니다. 예를 들어, 2024년 1월 영국 바이오 제약사 아스트라제네카(AstraZeneca)는 천식 치료제 AIRSUPRA(알부테롤/부데소니드)를 발표하였습니다. 단시간 작용 베타2 작용제(SABA)인 알부테롤과 흡입용 코르티코스테로이드(ICS)인 부데소니드의 합제이며, 천식 치료제로서 특별히 설계된 FDA가 승인한 최초이자 유일한 합제입니다. 이 흡입제는 한 번의 흡입으로 증상과 염증을 모두 치료하며, 악화 시 기관지 확장 및 기도 염증에 대한 신속한 표적을 제공합니다. 18세 이상의 환자를 대상으로 하며, 다른 조절제에 대한 의존도를 줄이면서 전반적인 천식 조절을 개선하는 것을 목표로 합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 천식 치료 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업 분석
세계의 천식 치료 시장 : 성장률 분석
세계의 천식 치료 시장 실적 : 규모와 성장, 2019-2024
세계의 천식 치료 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계의 천식 치료 : 총 잠재 시장 규모(TAM)
제6장 시장 세분화
세계의 천식 치료 시장 치료별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
장기 관리약
속효성약
세계의 천식 치료 시장 : 디바이스 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
흡입기
건조 분말
정량 분무식
소프트 미스트 네블라이저
세계의 천식 치료 시장 : 약물 종류별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
단시간 작용형 β자극제(SABA)
장시간 작용형 β자극제(LABA)
흡입 코르티코스테로이드(ICS)
류코트리엔 조절약
면역조절제
복합제
기타 약물 클래스
세계의 천식 치료 시장 : 투여 경로별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
경구
흡입
정맥내
피하
세계의 천식 치료 시장 : 유통 채널별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
병원 약국
소매 약국
온라인 약국
기타 유통 채널
세계의 천식 치료 시장 : 하위 세분화 장기 관리약(종류별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
흡입 코르티코스테로이드(ICS)
장시간 작용형 β자극제(LABA)
류코트리엔 수용체 길항제(LTRA)
장시간 작용형 무스카린 길항제(LAMA)
메틸 크산틴
생물학적 제제
세계의 천식 치료 시장 : 하위 세분화 속효성약(종류별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
단시간 작용형 β자극제(SABA)
전신성 코르티코스테로이드
항콜린제
제7장 지역별·국가별 분석
세계의 천식 치료 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
세계의 천식 치료 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
천식 치료 시장 : 경쟁 구도
천식 치료 시장 : 기업 개요
Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업과 혁신적 기업
Bayer AG
Novartis AG
Sanofi S.A.
AstraZeneca PLC
GlaxoSmithKline plc
Takeda Pharmaceutical Company Limited
Amgen Inc.
Boehringer Ingelheim International GmbH
Teva Pharmaceutical Industries Limited
Regeneron Pharmaceuticals Inc.
Sun Pharmaceutical Industries Limited
Genentech Inc.
Sumitomo Pharma Co Ltd.
Chiesi Farmaceutici S.p.A.
Cipla Limited
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병
제34장 최근의 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
천식 치료 시장 2029 : 새로운 기회를 제공하는 국가
천식 치료 시장 2029 : 새로운 기회를 제공하는 부문
천식 치료 시장 2029 : 성장 전략
시장 동향에 기반한 전략
경쟁 전략
제36장 부록
KSM
영문 목차
영문목차
Asthma treatment involves the medical approaches and management techniques aimed at controlling and alleviating asthma symptoms, preventing attacks, and enhancing lung function in affected individuals. This treatment focuses on reducing airway inflammation and managing symptoms to improve breathing.
The primary categories of asthma treatment include long-term control medications and quick-relief medications. Long-term control medications are taken daily to maintain asthma control and prevent symptoms. Devices used for administering these treatments include inhalers, dry powder inhalers, metered-dose inhalers, and soft mist nebulizers. Drug classes involved are short-acting beta-agonists (SABA), long-acting beta-agonists (LABA), inhaled corticosteroids (ICS), leukotriene modifiers, immunomodulators, combination drugs, and others. Administration routes encompass oral, inhaled, intravenous, and subcutaneous methods. These medications are distributed through various channels, including hospital pharmacies, retail pharmacies, online pharmacies, and others.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.
The asthma treatment market research report is one of a series of new reports from The Business Research Company that provides asthma treatment market statistics, including asthma treatment industry global market size, regional shares, competitors with an asthma treatment market share, asthma treatment market segments, market trends and opportunities, and any further data you may need to thrive in the asthma treatment industry. This asthma treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The asthma treatment market size has grown steadily in recent years. It will grow from $22.69 billion in 2024 to $23.75 billion in 2025 at a compound annual growth rate (CAGR) of 4.7%. The growth during the historic period can be attributed to rising urbanization and pollution levels, increased use of inhalers and nebulizers, improved healthcare access in emerging markets, heightened awareness and diagnosis rates, and greater exposure to allergens.
The asthma treatment market size is expected to see steady growth in the next few years. It will grow to $28.27 billion in 2029 at a compound annual growth rate (CAGR) of 4.5%. The anticipated growth in the forecast period can be linked to an increasing emphasis on personalized asthma treatments, greater adoption of biologics and monoclonal antibodies, rising investments in respiratory drug research and development, expanded use of telehealth and digital asthma management tools, and enhanced government initiatives focused on chronic respiratory care. Key trends expected include progress in biologic therapies for severe asthma, development of advanced digital inhalers with tracking capabilities, innovations in personalized medicine, improvements in drug-delivery technologies, and advancements in AI-powered asthma management platforms.
The rising prevalence of respiratory disorders is expected to drive the growth of the asthma treatment market in the coming years. Respiratory disorders encompass diseases that affect the lungs and breathing, such as chronic obstructive pulmonary disease (COPD), bronchitis, and asthma. This increase is largely linked to air pollution, as particulate matter and nitrogen oxides irritate and inflame the airways, causing breathing difficulties and worsening conditions like asthma. The growing number of respiratory disorder cases is boosting demand for asthma treatments, which include medications, inhalers, and lifestyle modifications to manage airway inflammation and symptoms. For example, in December 2023, the National Library of Medicine, a US-based institution, reported that by 2050, COPD cases in low- and middle-income countries are expected to more than double those in high-income countries, with sub-Saharan Africa projected to see a 59% rise and lead globally in COPD prevalence and cases by 2040. Thus, the increasing prevalence of respiratory disorders is fueling growth in the asthma treatment market.
Leading companies in the asthma treatment market are focusing on developing innovative products, such as anti-inflammatory rescue inhalers, to provide rapid symptom relief while simultaneously addressing airway inflammation in asthma patients. Anti-inflammatory rescue inhalers deliver quick relief during asthma attacks and reduce underlying airway inflammation. For instance, in January 2024, AstraZeneca, a UK-based biopharmaceutical firm, introduced AIRSUPRA (albuterol/budesonide), a novel inhaler for asthma. It is the first and only FDA-approved fixed-dose combination of albuterol, a short-acting beta2-agonist (SABA), and budesonide, an inhaled corticosteroid (ICS), designed specifically as a rescue medication for asthma. This inhaler provides fast bronchodilation and targets airway inflammation during exacerbations, treating both symptoms and inflammation with a single inhalation. It is intended for patients aged 18 and older and aims to improve overall asthma control while reducing dependence on separate controller medications.
In January 2024, GSK plc, a UK-based pharmaceutical company, acquired Aiolos Bio for an undisclosed amount. Through this acquisition, GSK intends to enhance its respiratory treatment portfolio and support long-term growth by combining Aiolos Bio's innovative therapies with its global presence to better serve patients worldwide. Aiolos Bio is a US-based clinical-stage biopharmaceutical company focused on asthma treatment.
Major players in the asthma treatment market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., AstraZeneca PLC, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Amgen Inc., Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Limited, Regeneron Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, Genentech Inc., Sumitomo Pharma Co Ltd., Chiesi Farmaceutici S.p.A., and Cipla Limited.
North America was the largest region in the asthma treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in asthma treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the asthma treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The asthma treatment market consists of revenues earned by entities by providing services such as diagnosis, medication administration, inhalation therapy, monitoring, and patient education. The market value includes the value of related goods sold by the service provider or included within the service offering. The asthma treatment market also includes sales of nebulizers, leukotriene modifiers, corticosteroids, and bronchodilators. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Asthma Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on asthma treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for asthma treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The asthma treatment market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Treatment: Long-Term Control Medications; Quick-Relief Medications
3) By Drug Class: Short-Acting Beta-Agonists (SABA); Long-Acting Beta-Agonists (LABA); Inhaled Corticosteroids (ICS); Leukotriene Modifiers; Immunomodulators; Combination Drugs; Other Drug Class
4) By Route Of Administration: Oral; Inhaled; Intravenous; Subcutaneous
5) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Other Distribution Channels
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Asthma Treatment Market Characteristics
3. Asthma Treatment Market Trends And Strategies
4. Asthma Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Asthma Treatment Growth Analysis And Strategic Analysis Framework
5.1. Global Asthma Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Asthma Treatment Market Growth Rate Analysis
5.4. Global Asthma Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Asthma Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Asthma Treatment Total Addressable Market (TAM)
6. Asthma Treatment Market Segmentation
6.1. Global Asthma Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Long-Term Control Medications
Quick-Relief Medications
6.2. Global Asthma Treatment Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Inhalers
Dry Powder
Metered Dose
Soft Mist Nebulizers
6.3. Global Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Short-Acting Beta-Agonists (SABA)
Long-Acting Beta-Agonists (LABA)
Inhaled Corticosteroids (ICS)
Leukotriene Modifiers
Immunomodulators
Combination Drugs
Other Drug Class
6.4. Global Asthma Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Inhaled
Intravenous
Subcutaneous
6.5. Global Asthma Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Other Distribution Channels
6.6. Global Asthma Treatment Market, Sub-Segmentation Of Long-Term Control Medications, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Inhaled Corticosteroids (ICS)
Long-Acting Beta-Agonists (LABA)
Leukotriene Receptor Antagonists (LTRA)
Long-Acting Muscarinic Antagonists (LAMA)
Methylxanthines
Biologics
6.7. Global Asthma Treatment Market, Sub-Segmentation Of Quick-Relief Medications, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Short-Acting Beta-Agonists (SABA)
Systemic Corticosteroids
Anticholinergics
7. Asthma Treatment Market Regional And Country Analysis
7.1. Global Asthma Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Asthma Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
